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Abstract
Background: Human cytomegalovirus (HCMV) is ubiquitous in the population but generally causes only mild or
asymptomatic infection except in immune suppressed individuals. HCMV employs numerous strategies for
manipulating infected cells, including mimicry of G-protein coupled receptors (GPCRs). The HCMV US27 gene
product is a putative GPCR, yet no ligand or signaling has been identified for this receptor. In the present study,
immunofluorescence microscopy was used to examine the cellular distribution of wild type US27, as well as US27
deletion mutants and chimeric receptors.
Results: In transiently transfected cells, wild type US27 was found primarily in intracellular compartments, in
striking contrast to the cell surface distribution seen for the human cellular chemokine receptor CXCR3. When the
N-terminal extracellular domains of the two receptors were swapped, no change in protein localization was
observed. However, swapping of the C-terminal intracellular domains resulted in a significant change in receptor
distribution. A chimera that contained US27 fused to the C-terminal intracellular tail of CXCR3 exhibited surface
distribution similar to that of wild-type CXCR3. When the C-terminal domain of US27 was fused to CXCR3, this
chimeric receptor (CXCR3/US27-CT) was found in the same intracellular pattern as wild-type US27. In addition, a
US27 mutant lacking the C-terminus (US27ΔCT) failed to accumulate inside the cell and exhibited cell surface
distribution. Co-localization with organelle-specific markers revealed that wild-type US27 was found predominantly
in the Golgi apparatus and in endosomal compartments, whereas the US27/CXCR3-CT chimera, US27ΔCT and
US27Δ348 mutants were not localized to endosomal compartments.
Conclusions: The results indicate that the C-terminal domain of the HCMV US27 protein, which contains a di-
leucine endocytic sorting motif, is both necessary and sufficient for intracellular localization, which may also help
explain why no cellular ligands have yet been identified for this viral receptor.
Keywords: HCMV, Cytomegalovirus, Chemokines, Chemokine receptors, GPCR, US27
Background
Human cytomegalovirus (HCMV) is a herpesvirus that
is ubiquitous in the population with a seroprevalence of
50-95% [1]. Primary infection is usually asymptomatic,
but more serious disease can occur in the immune-com-
promised patient. HCMV pneumonitis greatly impacts
the morbidity and mortality of transplant recipients, and
increasing numbers of HIV patients have been diag-
nosed with severe HCMV retinitis [2]. HCMV can also
be transmitted from mother to child during pregnancy
and remains the most common viral cause of congenital
defects, including deafness and mental retardation [3].
In the healthy host, HCMV maintains a successful co-
existence facilitated by numerous mechanisms that the
virus has acquired for modulating the host immune
response [4]. The virally encoded US2, US3, US6 and
US11 gene products all interfere with antigen processing
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patibility complex (MHC) class I presentation [5], and
thus decreased recognition by cytotoxic T lymphocytes.
In addition, the UL18 gene product is a homolog of the
MHC class I protein that is postulated to act as a decoy
on the cell surface to assist in the evasion of natural
killer cells [6]. A homolog of interleukin-10 encoded by
UL111A was found to inhibit inflammatory cytokine
secretion [7,8], and an a-chemokine encoded by UL146
has been shown to stimulate neutrophil migration [9].
In addition, the HCMV genome encodes four putative
GPCRs containing seven transmembrane domains and
similarity to human chemokine receptors: US27, US28,
UL33, and UL78 [10]. Chemokines are a class of cyto-
kines important in their regulation of motility and acti-
vation of immune cells, and the existence of viral
homologs of chemokine receptors indicates additional
mechanisms for manipulation of the host immune
response.
The US28 gene product is perhaps the most exten-
sively characterized viral GPCR; it is expressed early in
infection and has been shown to bind to a broad range
of human chemokines, including fractalkine, RANTES,
and MIP-1a [11-14]. The US28 receptor couples to a
variety of G proteins, including Gaq,G ai/o,G a12,a n d
Ga16 [12,15,16]. In in vitro assay systems with various
cell types expressing US28, chemokine binding has been
shown to induce an assortment of intracellular
responses, including calcium mobilization, MAP kinase
activation, cell migration, and activation of transcription
factors, such as NFAT, CREB, and NF-B [11-13,15,17].
Ligand-independent signaling has also been observed for
the US28 receptor; constitutive phospholipase C activa-
tion and inositol phosphate (IP3) production occur in
transfected Cos-7 and Hela cells expressing US28
[12,18]. Expression of US28 transcripts occurs through-
out the infection cycle, at immediate early, early, and
late time points [14,19], as well as during latency in
THP-1 monocytes [20]. Although no homologs of this
receptor exist in the genomes of rodent CMVs, five tan-
dem homologs of US28 have been identified in the gen-
ome of Rhesus CMV [21]. The US28 protein is a
versatile viral receptor with the ability to alter signaling
networks during infection in many different ways.
The UL33 gene of HCMV is highly conserved among
herpesviruses, with homologs in rat CMV (RCMV R33)
and murine CMV (MCMV M33), as well as the U12
genes of HHV-6 and HHV-7. UL33, R33, and M33 have
all been found to display constitutive signaling activity,
as evidenced by modulation of CRE (cAMP response
element)-mediated transcription [22,23]. To date, no
ligands have been identified for these receptors, and the
UL33 homologs from all CMVs remain orphans.
A l t h o u g hU L 3 3 ,R 3 3 ,a n dM 3 3a r ea l ld i s p e n s a b l ef o r
virus replication in vitro [24-26], the biological signifi-
cance of UL33 family members has been demonstrated
in in vivo studies. A deletion mutant of MCMV lacking
functional M33 demonstrated impaired replication in
the salivary glands of infected mice [25,27], and M33 is
widely considered to be a functional homolog of HCMV
US28. Likewise, when immune-compromised rats were
infected with a recombinant RCMV strain lacking R33,
no virus replication was observed in the salivary glands
and animals infected with the mutant strain had lower
mortality rates than those infected with wild-type virus
[26], suggesting that this protein plays a role in patho-
genesis in vivo.
The initial analysis of the HCMV genome predicted
the presence of only three GPCRs, US27, US28, and
UL33 [28]. Subsequent analysis defined a fourth putative
GPCR, UL78, based on similarity to an HHV-6 gene
[29]. Microarray analysis of HCMV-infected fibroblasts
indicates that UL78 is expressed at the early stage of
infection [30]. Homologs of UL78 exist in the genomes
of the rodent CMVs. MCMV M78 exists as a dimer that
is rapidly endocytosed [31]; the gene is transcribed at
early times in infected cells and was also found to be
present in the virus envelope [32]. In contrast, RCMV
R78 is expressed both early and late in infection [33].
While UL78 is not required for HCMV replication in
vitro, as demonstrated by the unimpaired growth of null
mutants in culture [34], mutant RCMV strains lacking
R78 have a syncytium-inducing phenotype in rat
endothelial fibroblasts and cause reduced mortality in
infected rats [33]. R78, like R33, appears to impact in
vivo viral pathogenesis.
US27 remains the least studied of the HCMV GPCRs,
and no homologs have been described for CMV strains
infecting other species. US27 is directly adjacent to
US28 in the HCMV genome and the two proteins share
31% sequence identity, leading to speculation that a
gene duplication event may have occurred. Although it
has not yet been shown to be a functional receptor, the
US27 gene product contains several features that are
characteristic of human chemokine receptors, such as
the seven-transmembrane a-helical domains. While
overall sequence homology among most GPCRs is low,
certain key residues tend to be highly conserved. For
instance, the DRY motif (aspartic acid-arginine-tyrosine)
is critical for receptor activation and stabilization [35],
and that motif is present in the second intracellular loop
of US27. The second and third extracellular domains of
US27 contain two conserved cysteine residues (C104
and C176, respectively) that have been shown to be
essential for structure and ligand binding for many
GPCRs [28,36,37]. In addition, the extracellular domain
of US27 has been shown to be heavily glycosylated [38],
a common characteristic among receptors that have
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neither ligands nor any ligand-independent constitutive
signaling [22] have been identified for this receptor so
far, these observations suggest that HCMV US27 may
be involved in the modification of host chemokine sig-
naling. The US27 gene product exhibits greatest amino
acid sequence identity with US28, followed closely by
human chemokine receptors CCR1 and CCR4 (29%
sequence identity for each).
US27 is expressed late in infection [40], and the 2.9 kb
transcript was found to be spliced within the 5’ untrans-
lated region, a possible indication that post-transcrip-
tional regulation of US27 gene expression occurs [41].
Both UL33 and US27 have been shown to be present in
the virion particle and in endocytic membrane compart-
ments of infected cells, suggesting that they may play a
role during virus infection [24,38,42]. Viral mutants that
lack the US27 gene are replication competent [14]; how-
ever, a slight growth defect was observed at low multi-
plicities of infection compared to wild type virus [43].
While the US27 deficient virus could spread directly
from cell to cell, the mutant failed to spread by an
extracellular route. Interestingly, no replication defi-
ciency was noted in a virus lacking both US27 and
US28 [14].
Although US27 is not required for lytic virus infection
in vitro, this does not preclude an important role for
this receptor in subverting the host immune response in
vivo. In this study, the US27 protein was expressed in
mammalian cells. Due to the predominantly intracellular
localization noted here and by others [42], a series of
deletion mutants and chimeric receptors were created in
order to identify specific protein domains required for
the subcellular distribution. We found that the C-term-
inal intracellular domain contained sequences that were
both necessary and sufficient for directing US27 to the
endosomes.
Results
In order to characterize the biological activities of the
HCMV US27 receptor, we first constructed an expres-
sion plasmid encoding US27. The US27 gene from
strain AD169 was cloned into the pcDNA3.1 vector,
allowing for expression of the US27 protein as a fusion
with a C-terminal myc/HIS epitope tag. US27 protein
expression was investigated via immunofluorescence
microscopy using human embryonic kidney cells
(HEK293) grown on glass cover slips and transiently
transfected with pcDNA-US27. After 48 hours, the cells
were fixed, permeabilized, and stained with an anti-myc
monoclonal antibody followed by a FITC-conjugated
goat anti-mouse secondary antibody. The US27 protein
(pUS27) was expressed in transfected cells and was
found in a predominantly intracellular pattern (Figure
1A). Nuclei appeared blue due to DAPI staining, and
the green fluorescence representing pUS27 was concen-
trated around the nucleus and in adjacent compart-
ments. The epitope tag is unlikely to have altered
distribution of pUS27, as transfection of HEK293 cells
with either p3XFLAG-US27, which enabled expression
of the protein with an N-terminal FLAG tag (Figures 2
and 3), or pEGFP-US27 (data not shown) resulted in the
same intracellular localization pattern. These results are
consistent with the perinuclear localization for pUS27
previously described in both transfected and infected
cells by Fraile-Ramos et al. [42].
Given the striking intracellular localization of pUS27,
we selected a more typical GPCR for comparison.
CXCR3 is a human chemokine receptor and the expres-
sion pattern, tissue distribution, ligands, and signaling
outcomes are well-characterized [44-47]. The CXCR3
gene was isolated from human peripheral blood mono-
nuclear cells and cloned into pcDNA3.1. Immunofluor-
escence of transiently transfected HEK293 cells revealed
that CXCR3 had a widespread distribution in which the
complete outline of the adherent cell was visible, which
is consistent with expression of this receptor on the cell
surface (Figure 1B). When expressed with an N-terminal
FLAG tag (Figure 3) or as an EGFP fusion protein (data
not shown) CXCR3 also exhibited the same cell surface
distribution.
To evaluate which domain of the US27 protein was
responsible for the distinct intracellular localization pat-
tern, a series of US27/CXCR3 receptor chimeras were
created. The N-terminal extracellular domain of pUS27
(aa 1-34) was replaced with the corresponding extracel-
lular domain of CXCR3, resulting in a fusion protein
that contained amino acids 1-55 from CXCR3 and
amino acids 34-362 of pUS27. Transient transfection of
HEK293 cells with plasmid DNA encoding this chimera
(pcDNA-CXCR3-NT/US27) revealed an intracellular
distribution similar to that of wild-type pUS27 (Figure
1C). Likewise, a chimera consisting of aa 1-33 of US27
and 56-336 of CXCR3 (US27-NT/CXCR3) was also cre-
ated, and this receptor retained the widespread surface
distribution characteristic of CXCR3 (Figure 1D).
Next, a chimera consisting of amino acids 1-303 from
pUS27 and the C-terminus of CXCR3 (aa 327-368) was
prepared. This receptor chimera (US27/CXCR3-CT) was
found to be expressed with a cell surface distribution
similar to that of wild-type CXCR3 (Figure 1E). In con-
trast, a chimera containing amino acids 1-336 of
CXCR3 and 304-362 of pUS27 (CXCR3/US27-CT) was
found to exhibit intracellular localization similar to that
of wild type pUS27 (Figure 1F). These findings strongly
suggest that sequences within the C-terminal intracellu-
lar domain of HCMV US27 contribute to the intracellu-
lar receptor distribution.
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receptor localization, flow cytometry was performed to
confirm whether receptors were found at the cell sur-
face. HEK293 cells that were stably transfected with
p3XFLAG constructs encoding US27, CXCR3, or chi-
meras were stained with anti-FLAG antibodies followed
by FITC-conjugated secondary antibody. As shown in
Figure 4A, cells stably transfected with p3XFLAG-US27
exhibited very little surface staining (solid lines) com-
pared to cells stained with an isotype control antibody
(dotted lines). Cells stably transfected with p3XFLAG-
CXCR3 were found to express a significant amount of
cell surface receptor. Chimeras containing swapped N-
terminal domains (CXCR3-NT/US27 and US27-NT/
CXCR3) exhibited staining that was markedly similar to
the wild-type receptor (pUS27 and CXCR3, respec-
tively). However, chimeras containing swapped C-term-
inal domains showed a significantly different expression
pattern. The US27/CXCR3-CT receptor was detected on
the cell surface, in direct contrast to the pattern
observed for wild type pUS27, whereas the CXCR3/
US27-CT receptor was not detected on the cell surface
at all. These results confirm the receptor distributions
observed when immunofluorescence staining was con-
ducted in the absence of any permeabilization of the
cells, as shown in Figure 4B. Almost no pUS27 was
detected, confirming that this receptor is largely absent
from the cell surface. Cells expressing CXCR3 could still
be visualized even without permeabilization, demon-
strating that this receptor is present on the cell surface.
The chimeric receptors demonstrate the distribution
predicted for the given C-terminal domain: US27/
CXCR3-CT was clearly visible at the surface while
CXCR3/US27-CT was virtually absent from the cell sur-
face. These results indicate that the C-terminal domain
of US27 conveys intracellular receptor localization.
To confirm that the C-terminal domain was necessary
for intracellular localization of the viral receptor, a
A.  US27 B.  CXCR3
C.  CXCR3-NT/US27
F. CXCR3/US27-CT
D.  US27-NT/CXCR3
E. US27/CXCR3-CT
Figure 1 Immunofluorescence images of cells expressing US27 and US27 chimeras. HEK293 cells were seeded onto glass coverslips,
transfected with the indicated pcDNA constructs, and then fixed and stained with anti-myc antibodies. After treatment with FITC-conjugated
anti-mouse secondary antibodies, the coverslips were mounted with Prolong Gold containing DAPI. Line drawings beside each photo depict
each 7TM receptor and the chimeras that were made using domains of US27 (black) and CXCR3 (red). Scale bars = 10 μm.
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acids 304-362 (US27ΔCT) was expressed. This truncated
receptor was found to display a more widespread cell
surface distribution with a punctate and speckled
appearance, similar to human CXCR3 (Figure 2). In
order to pinpoint whether specific amino acids might
mediate this intracellular localization, a series of succes-
sive truncations to the C-terminal domain of pUS27
were made. The US27Δ348, US27Δ338, and US27Δ322
mutants all displayed the same punctate but widespread
surface distribution as the US27ΔCT protein (Figure 2).
The same expression pattern was observed when the
cells were stained in the presence or absence of permea-
bilization (data not shown). This could indicate that the
amino acids mediating the intracellular localization of
the US27 receptor are located at the very C-terminus of
the protein between residues 348-362, since this region
was absent from all of the deletion mutants examined.
Interestingly, this region contains two leucine residues
preceded by a series of acidic amino acids (amino acids
349-362 EEEFLL), which is a known sorting and inter-
nalization signal [48-50]. Thus, the results indicate that
deletion of amino acids 348-362 ablates the intracellular
localization seen for wild-type pUS27, possibly due to
the loss of the di-leucine sorting motif.
To more precisely determine the subcellular location
of wild type pUS27, HEK293 cells that stably expressed
FLAG-tagged US27 proteins were analyzed by immuno-
fluorescence microscopy. The US27 protein was found
in compartments adjacent to the nucleus. These same
compartments appeared red when labeled with an anti-
body specific for GMP130, a marker for cis-medial
Figure 2 Expression of US27 deletion mutants in transfected cells. HEK293 cells were seeded onto glass coverslips, transfected with the
indicated p3XFLAG constructs, and then fixed and stained with permeabilization with anti-FLAG antibodies as described. Scale bars = 10 μm.
The amino acid sequence of the C-terminal intracellular domain of US27 and each truncation mutant is shown.
US27 CXCR3 
US27/CXCR3-CT CXCR3/US27-CT 
Figure 3 US27 is found at the cell surface only transiently.
Stably transfected HEK293 cells were grown on glass coverslips in
culture medium containing anti-FLAG antibodies for one hour, then
washed, fixed, permeabilized, and stained with the appropriate
secondary antibody. Scale bars = 10 μm.
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Figure 4 Cell surface staining of US27. A) HEK293 cells were transiently transfected with the indicated p3XFLAG constructs, harvested via
gently scraping, staining with anti-FLAG antibodies, then examined via flow cytometry using a BD FACSCalibur. Data was analyzed using
CellQuestPro. B) Transiently transfected cells grown on glass coverslips were fixed and stained in the absence of any detergents or
permeabilization steps. After treatment with FITC-conjugated anti-mouse secondary antibodies, the coverslips were mounted with Prolong Gold
containing DAPI. Scale bars = 10 μm.
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localization of pUS27 with the Golgi apparatus, which is
consistent with the observation that this protein is heav-
ily glycosylated [38]. In addition, there was evidence that
pUS27 was also present in the endosomes, which were
stained with antibody to EEA1, early endosomal antigen
1. The distribution pattern was specific for the Golgi
apparatus and endosomal compartments, as pUS27 did
not significantly co-localize with a marker for the endo-
plasmic reticulum (calreticulin) or the lysosomes
(LAMP2, lysosomal associated membrane protein 2).
The results demonstrate that intracellular pUS27 is
found mainly in the Golgi apparatus and endosomes.
In order to eliminate the possibility that pUS27 was
simply retained inside the cell due to improper folding
or other transport issues, antibody feeding experiments
were performed. Briefly, stably transfected cells were
cultured in the presence of anti-FLAG antibodies, then
the cells were fixed, permeabilized, and stained with
FITC conjugated secondary antibody. As shown in Fig-
ure 3, cells expressing pUS27 exhibit modest green
fluorescence in the same perinuclear intracellular
Figure 5 US27 co-localizes with Golgi and endosome markers. A stable p3XFLAG-US27 HEK293 cell line was stained with anti-FLAG
antibodies and antibodies to the indicated organelles followed by FITC conjugated anti-mouse and TRITC-conjugated anti-rabbit secondary
antibodies. Blue represents the DAPI-stained nuclei, green represents US27, and red represents organelles. The merged images result from
imaging that compiles all three color images into one. Areas where green and red co-localize appear yellow. Scale bars = 10 μm.
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strongly indicates that the viral receptor is synthesized
normally and transported to the cell surface, but it
remains there only transiently before internalization.
These findings support the notion that sequences in the
C-terminal domain of pUS27 are responsible for the
intracellular localization pattern. When the subcellular
location of the US27/CXCR3-CT chimera was exam-
ined, however, there was no evidence of co-localization
with endosomal markers (Figure 6). In addition, neither
the US27ΔCT nor the US27Δ348 mutants were found
to be concentrated in endosomal compartments. Alto-
gether, these results demonstrate that the C-terminus of
pUS27 is both necessary and sufficient for intracellular
receptor localization to the endosomes.
Discussion
HCMV has a remarkable capacity to institute life-long
latent infections, largely as a result of having multiple
mechanisms for modifying host immune responses. The
virus expresses four proteins with homology to the
GPCR superfamily, only one of which, US28, has been
shown to function as a ligand-activated chemokine
receptor to date.
In setting out to characterize the function of US27, we
were first struck by the unusual cellular localization pat-
tern. Most GPCRs are found in the plasma membrane,
with an extracellular ligand binding domain displayed
on the cell surface for access by ligands. In contrast,
US27 was found predominantly inside the cell. Our
results using transfected cells here are consistent with
previous reports that have shown US27 to have an intra-
cellular perinuclear distribution in both transfected and
virus infected cells [42,51]. We further examined the
distribution pattern by creating a series of receptor chi-
meras that contained domains of US27 and domains
from the human chemokine receptor CXCR3. This
receptor was originally selected as a fusion partner for
use in a calcium signaling screen to identify possible
chemokine ligands for US27. The closely related HCMV
receptor US28 is relatively promiscuous and binds a
large number of human chemokines, but US28 does not
Endosome Nucleus  US27  Mutant  Merge 
US27/CXCR3-CT 
US27'CT 
US27'348 
Figure 6 US27 mutants do not co-localize with the endosome marker. HEK293 cells were transfected with p3XFLAG constructs expressing
the chimeric receptor US27/CXCR3-CT, deletion mutant US27ΔCT, or US27Δ348. Cells were co-stained with anti-FLAG and antibodies to the early
endosomal antigen as described. Endosomes appear red, nuclei blue, and US27 mutants green. Scale bars = 10 μm.
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(CXCL9/MIG, CXCL10/IP-10, and CXCL11/I-TAC).
Thus, it was expected that using CXCR3 as a fusion
partner was unlikely to result in identification of any
false positive ligands for US27. In fact, the ligand screen
failed to identify any human chemokine that caused cal-
cium flux through wild type US27 or the US27/CXCR3-
CT chimera (data not shown), but the unusual localiza-
tion of the distribution of these receptors warranted
further study.
Through immunofluorescence imaging of transiently
transfected cells, wild-type pUS27 was found to be loca-
lized to intracellular compartments, whereas both the
US27 fusion protein expressing the C-tail of CXCR3
(US27/CXCR3-CT) and US27 with a truncated C-termi-
nus exhibited altered localization to the cellular surface
(Figure 1E and 2, respectively). Moreover, the expression
profile of US27/CXCR3-CT was more comparable to
that of CXCR3 (Figure 1E, B). These findings are further
supported by flow cytometry (Figure 4) and clearly
demonstrate that the C-terminal amino acids of US27
are required for intracellular localization, since either
removal or replacement of this domain ablates the intra-
cellular distribution pattern.
Another chimera, CXCR3/US27-CT, was found mainly
inside the cell, in a pattern that was distinct from that of
wild-type CXCR3 but instead resembled that of wild-
type pUS27. These results show that the C-terminal
domain is sufficient to convert a cell surface receptor to
an intracellular one. Likewise, a chimera that contained
the N-terminal domain of CXCR3 and the remainder of
the US27 receptor was found clustered around the
nucleus inside the cell, further demonstrating that the
C-terminal domain is what determines US27 receptor
localization.
In a similar study, Waldhoer et al. [52] generated chi-
meric and mutant HCMV US28 proteins and found
them to possess altered constitutive endocytic proper-
ties. The capacity of the C-terminal tail of US28 to med-
iate constitutive receptor endocytosis was transposable
to membrane-localized GPCRs such as the endogenous
NK1 receptor and ORF74 GPCR of HHV-8. Alterna-
tively, replacing the C-tail of US28 with the C-terminal
tails of the NK1 or ORF74 receptors yielded a predomi-
nant surface localization phenotype for the US28
receptor.
In the same study, removal of the C-tail of US28 was
found to enhance signaling induced by fractalkine, per-
haps due to increased availability of the receptor on the
cell surface [52]. We have not yet had the opportunity
to determine whether removal of the C-terminal domain
of US27 impacts cell signaling, as there are no known
ligands or signaling outcomes for US27 at this time.
Interestingly, a previous report had suggested that US27
might bind to RANTES based on chemokine internaliza-
tion studies with mutant viruses lacking either US27,
US28, or both [14]. In this study, cells infected with
wild type virus internalized RANTES whereas cells
infected with a mutant lacking both US27 and US28 did
not. Cells infected with virus mutants lacking either
US27 or US28 internalized RANTES, albeit to a lesser
extent than cells infected with wild type virus. However,
RANTES binding to US27 has not yet been confirmed
and we have observed no calcium flux or migration of
HEK293 cells expressing either US27 or US27/CXCR3-
CT in response to RANTES (data not shown).
We have demonstrated that the C-tail of HCMV US27
mediates intracellular localization, which is most likely
due to interactions with cellular proteins. A previous
study investigating the interactions between a library of
C-terminal tails and various post-endocytic sorting pro-
teins found that US27 associates with N-ethylmalei-
mide-sensitive factor, or NSF [53]. A hexameric ATPase,
N S Fi sa na d a p t e rp r o t e i ni n v o l v e di np o s t - e n d o c y t i c
sorting of GPCR. As shown here, the intracellular, peri-
nuclear localization seen in the expression of wild-type
US27 was replaced with more diffused and surface loca-
lized expression patterns due to truncations of the C-
terminus (Figure 2). These findings suggest that the C-
terminus of US27 is necessary for endocytic trafficking
and the resultant predominant intracellular localization
of the receptor, as likely mediated through the associa-
tion of the C-tail with NSF or other post-endocytic sort-
ing proteins.
Indeed, more detailed analysis of the C-terminal
domain of US27 revealed that deletion of 14 amino
acids from the C-terminus had the most pronounced
effect on receptor localization (Figure 2). We are confi-
dent that this result is due to the loss of specific amino
acids and not simply modification of protein folding or
expression patterns, as we have produced numerous
other chimeras, deletions, and point mutations that do
not alter the distribution of pUS27 (data not shown).
Furthermore, analysis of the amino acid sequence of the
C-terminus of US27 using the Eukaryotic Linear Motif
( E L M )r e s o u r c e[ 5 4 ]s h o w st h ep r e s e n c eo fak n o w n
sorting and internalization signal, EEEFLL (amino acids
349-362). Di-leucine motifs mediate internalization from
the cell surface and have been described for numerous
proteins including the CD3 and CD4 proteins of T lym-
phocytes [48,49], interferon-g receptor [55], opioid
receptors [50], and the thrombin receptor PAR1 [56]. In
addition, the Env and nef proteins of HIV have di-leu-
cine motifs that are critical for virus replication and
optimal infectivity [27,57]. Receptor internalization
mediated by di-leucine motifs can be followed by either
lysosomal targeting and receptor degradation or by
accumulation in endocytic compartments and recycling
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acidic amino acid residue four or five residues N-term-
inal to the di-leucine motif has been shown to result in
inclusion in endocytic compartments and not targeting
to the lysosomes [54]. The US27 sequence contains
multiple acidic residues upstream of the di-leucine
motif, which is consistent with our observations that the
US27 receptor is infrequently found on the cell surface
but instead localizes to the Golgi apparatus and endoso-
mal compartments. A similar motif is found in the C-
terminal domain of US28 (aa 301-306, ELHCLL) and
has been shown to be responsible for mediating interac-
tion of US28 with the AP-2 adapter complex [56]. Addi-
tional studies are underway to determine whether US27
binds directly to AP-2 and other intracellular sorting
proteins. Interestingly, CXCR3 contains three leucine
residues in the C-terminal domain (aa 332-334) but
these are positioned near the cell membrane and do not
appear to function as an endocytic sorting signal.
Due to the absence of an in vivo model for HCMV
infection, the roles of US27 and US28 in the pathogenesis
of HCMV infection in humans remains unclear. Given the
numerous reports of US28 signaling activity, is seems that
this protein must convey valuable immune evasion func-
tions. For example, it has been suggested that US28 may
act to scavenge inflammatory chemokines, removing them
from the extracellular milieu and thus impairing leukocyte
recruitment [14]. For US27, with no known ligands or sig-
naling outcomes, the picture is even murkier. Viruses gen-
erally only retain genes that are beneficial to their survival,
so it is likely that US27 serves an important, but as yet
unknown, role in HCMV infection as well. Our results
show that US27 is found predominantly inside the cell,
and antibody feeding experiments confirm that the recep-
tor does travel to the cell surface, only to be internalized
again. Even in the absence of any chemokine binding, it is
tempting to speculate that US27 could alter leukocyte traf-
ficking of infected cells through endocytosis that results in
the internalization of cellular chemokine receptors, ren-
dering cells unresponsive to certain chemokine signals. In
addition, recent studies have shown that US28 can form
heterodimers with UL33 and UL78, and that heterodimeri-
zation can abrogate US28-mediated signaling [51].
Ongoing studies are aimed at investigating whether US27
forms dimers with other viral or cellular receptors and
determining the true role of this receptor in virus infection
and pathogenesis.
Materials and methods
Virus, cells, and antibodies
The AD169 strain of HCMV was used for these studies
(ATCC, Manassas, VA). WI-38 human lung fibroblasts
and human embryonic kidney cells (HEK293) were
maintained in Eagle’s minimum essential medium
supplemented with 10% fetal bovine serum (Atlanta Bio-
logicals, Atlanta, GA) in a humidified 37°C incubator
with a 5% CO2 environment. Human peripheral blood
mononuclear cells (PBMC) were isolated from the buffy
coat of a healthy human donor and cultured in RPMI
1640 supplemented with 2 mM glutamine, 10 mM
HEPES, 1 mM sodium pyruvate, 1.5 g/L sodium bicar-
bonate and 10% fetal bovine serum.
Anti-myc antibodies were obtained from Invitrogen
(San Diego, CA) and the anti-FLAG antibody was from
Sigma-Aldrich (St. Louis, MO). Organelle-specific anti-
bodies were from GeneTex (Irvine, CA). The Golgi
apparatus was detected with an antibody to Golgi
Matrix Protein GM130, lysosomes were detected with
an antibody to lysosomal-associated membrane protein
2 (LAMP2/CD107b), and endosomes were detected with
an antibody to early endosome antigen 1 (EEA1). FITC-
conjugated goat anti-mouse secondary antibodies, goat
anti-rat TRITC and goat anti-rabbit TRITC secondary
antibodies were from Anaspec (San Jose, CA). The
endoplasmic reticulum was labeled via transfection
using a Cell Painter plasmid (Origene, Rockville, MD)
expressing RFP-calreticulin.
Receptor constructs
The full length US27 gene was amplified via PCR using
DNA harvested from AD169 infected cells at 14 days
post-infection as a template, and the following gene spe-
cific primers: US27 forward 5’-CGGATCCATGAC-
CACCTC TACAAATAATC-3’ and US27 reverse 5’-
GCTCGAGTTACAACAGAAATTCCTCCT C-3’.T h e
resulting 1.1 kb PCR product was digested with BamHI
and XhoI and then cloned into the corresponding sites
of pcDNA3.1/myc-HisA (Invitrogen) to express the viral
receptor with myc and 6XHis epitope tags at the car-
boxy-terminus. The full length US27 gene was also
cloned into the HindIII and BamHI sites of p3XFLAG-
CMV10 (Sigma-Aldrich) to generate the viral receptor
with three adjacent FLAG epitopes at the N-terminus of
the protein. Finally, full length US27 was cloned into
the XhoI and BamHI sites of pEGFP-C1 (Clontech,
Mountain View, CA) to create an EGFP-US27 fusion
protein. DNA sequencing confirmed that the US27
sequence did not differ from the published sequence of
the gene (Genbank accession #NC_001347, whole gen-
ome of HCMV strain AD169).
The full length gene for human chemokine receptor
CXCR3 was amplified via RT-PCR from RNA isolated
from human PBMCs using the following gene specific pri-
mers: CXCR3 forward 5’-CGGATCCATGGTCCTT-
GAGGTGAGTGAC-3’ and CXCR3 reverse 5’-
GCTCGAGTCACAAGCCCG AGTAGGAG-3’.T h e
resulting 1.1 kb PCR product was digested with BamHI
and XhoI and then cloned into the corresponding sites of
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receptor with myc and 6XHis epitope tags at the carboxy-
terminus. The full length CXCR3 gene was also cloned
into the BamHI/HindIII sites of p3XFLAG-CMV10 and
the HindIII/XhoI sites of pEGFP-C1 to create tagged
fusion proteins as described above. DNA sequencing con-
firmed the CXCR3 sequence was the same as the pub-
lished sequence (Genbank accession # AY242128).
Chimeric receptors consisting of segments of HCMV
US27 fused to regions of human CXCR3 were created
using a two-step PCR strategy. The 3’ region of CXCR3
(nucleotides 979-1104) corresponding to amino acids
327-368 of the intracellular C-terminal domain was
amplified using the CXCR3 reverse primer above with a
forward primer containing an extended region that did
not anneal to CXCR3 but was complementary to the 3’
end of the US27 fragment (5’-GGCACTCAAATGAG-
GAAGGAGCGGATGTGGATGCTGCTC-3’). Likewise,
the region of US27 between nucleotides 1-909 was
amplified using the US27 forward primer and a reverse
primer containing an extended region complementary to
the 5’ end of the CXCR3 fragment (5’-CAGCATCCA-
CATCCGCTCCTTCCTCATTTGAGTGCCTAC-3’).
These two fragments were the templates for a second
round of PCR using the US27 forward primer and the
CXCR3 reverse primer, resulting in a full length product
containing nt 1-909 of US27 and nt 979-1104 of
CXCR3. This 1 kb product was then purified, digested
with restriction enzymes, and cloned into the BamHI/
XhoI sites of the pcDNA3.1-myc/HisA vector. After
transformation, DNA sequencing of a resulting positive
clone confirmed it contained the sequence of US27
from nucleotides 1-909 and CXCR3 from 910 to 1032;
this clone was designated US27/CXCR3-CT.
Three additional chimeras were produced using the
same approach. CXCR3/US27-CT consisted of nucleo-
tides 1-978 of CXCR3 and nucleotides 910-1089 of
US27, CXCR3-NT/US27 comprised nucleotides 1-159 of
CXCR3 and nucleotides 109-1089 of US27, and US27-
NT/CXCR3 comprised nucleotides 1-108 of US27 and
nucleotides 160-1032 of CXCR3. In addition, four US27
deletion mutants were created using PCR to truncate
the coding sequence. US27ΔCT comprises nucleotides
1-908 of US27, US27Δ322 contains nucleotides 1-966,
US27Δ338 contains nucleotides 1-1014, and US27Δ348
contains nucleotides 1-1044. Each chimeric gene or
deletion mutant was cloned into the BamHI/XhoI sites
of pcDNA3.1 and the HindIII/BamHI sites of p3XFLAG.
Transient transfection and immunofluorescence
microscopy
HEK293 cells were seeded in six-well dishes (2 × 10
5
cells per well) containing glass coverslips and then
transfected with US27 or CXCR3 constructs and Fugene
transfection reagent (Roche, Basel, Switzerland) accord-
ing to the manufacturer’s instructions. At 48 hours
post-transfection, the cells were washed with PBS, fixed
with 2% paraformaldehyde, permeabilized (where indi-
cated) with 0.2 (w/v) Triton X-100, and then further
treated with a mixture of 50% methanol-50% acetone.
After blocking with PBS + 10% FBS, the cells were
stained with primary antibody (1:250 dilution) at 37°C
for one hour. After washing, the cells were incubated
with fluorochrome-conjugated secondary antibody for
one hour, washed again, then dried and mounted using
Prolong Gold anti-fade reagent with DAPI (Invitrogen).
Slides were viewed using a Zeiss A1 AxioObserver fluor-
escence microscope and image acquisition and analysis
was performed using AxioVision software.
Stable cell lines and co-localization experiments
HEK293 cells were transfected with p3XFLAG-US27 as
described and then cultured in the presence of 1 mg/ml
geneticin sulfate (Invitrogen) to select for stable trans-
formants. After several weeks of continuous selection, a
clonal cell line was prepared by limiting dilution assay
and expression of FLAG-tagged US27 was confirmed via
fluorescence microscopy following staining with anti-
FLAG antibody. For co-localization studies, stable
3XFLAG-US27 cells were seeded onto glass coverslips
and stained with anti-FLAG and the indicated organelle
specific antibodies, followed by FITC-conjugated anti-
mouse and TRITC-conjugated anti-rabbit secondary
antibody. For co-localization with the ER marker,
3XFLAG-US27 stable cells were transfected with
pCMV6-AC-RFP-calreticulin and stained with anti-
FLAG and viewed 48 hours post-transfection. For anti-
body feeding assays, stably transfected HEK293 cells
were grown on glass coverslips in medium containing
the anti-FLAG antibody at 37°C for one hour, then
fixed, permeabilized, and stained with FITC-conjugated
anti-mouse secondary antibody prior to mounting with
Prolong Gold anti-fade reagent with DAPI (Invitrogen).
Flow Cytometry
HEK293 cells were transfected as described and 48
hours post-transfection cells were washed in PBS, then
harvested and resuspended in FACS buffer (PBS + 1%
BSA and 0.1% sodium azide) for surface staining with
anti-FLAG antibody (1:100 dilution) followed by FITC-
conjugated secondary antibody. Cells were stained for
one hour on ice in the dark, then washed three times,
fixed in 1% paraformaldehyde, and analyzed using a
FACSCalibur and CellQuestPro software.
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